Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating-factor-mediated pathogenesis in Lyme disease

E Isogai1, K Kimura, N Fujii

  • 1Department of Preventive Dentistry, Health Sciences University of Hokkaido, Japan.

Infection and Immunity
|March 1, 1996
PubMed
Summary

Platelet-activating factor (PAF) may induce inflammation during Borrelia burgdorferi infections. Blocking PAF reduced inflammatory responses in skin lesions and inhibited platelet aggregation with leukocytes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tat pathway-mediated translocation of the Sec pathway substrate OprM, an outer membrane subunit of the resistance nodulation division xenobiotic extrusion pumps, in Pseudomonas Aeruginosa.

Chemotherapy·2013
Same author

Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients.

International journal of STD & AIDS·2010
Same author

Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria.

Oral microbiology and immunology·2009
Same author

Changes in epidemiology of leptospirosis in 2003--2004, a two El Niño Southern Oscillation period, Guadeloupe archipelago, French West Indies.

Epidemiology and infection·2007
Same author

Lyme borreliosis incidence in two French departments: correlation with infection of Ixodes ricinus ticks by Borrelia burgdorferi sensu lato.

Vector borne and zoonotic diseases (Larchmont, N.Y.)·2007
Same author

[Laboratory based human leptospirosis surveillance in New Caledonia (2001-2005)].

Bulletin de la Societe de pathologie exotique (1990)·2007

Area of Science:

  • Immunology
  • Microbiology
  • Dermatology

Background:

  • Borrelia burgdorferi causes Lyme disease, a tick-borne illness.
  • Inflammation is a key component of the host response to bacterial infections.
  • Platelet-activating factor (PAF) is a potent inflammatory mediator.

Purpose of the Study:

  • To investigate the role of platelet-activating factor (PAF) in Borrelia burgdorferi infection.
  • To determine if PAF contributes to the inflammatory process in Lyme disease skin lesions.
  • To assess the effect of PAF antagonism on host-pathogen interactions.

Main Methods:

  • Utilized a PAF antagonist to block PAF activity in a model of Borrelia burgdorferi infection.
  • Assessed the inflammatory response in skin lesions of infected subjects.

Related Experiment Videos

  • Examined the impact of the PAF antagonist on platelet aggregation in the presence of Borrelia burgdorferi and polymorphonuclear leukocytes.

    • Main Results:

    • Administration of a PAF antagonist significantly reduced the inflammatory response observed in skin lesions.
    • The PAF antagonist inhibited platelet aggregation when Borrelia burgdorferi spirochetes were incubated with polymorphonuclear leukocytes.
    • These findings suggest a direct link between PAF and the inflammatory cascade in this infection.

    Conclusions:

    • Platelet-activating factor (PAF) plays a significant role in mediating inflammation during Borrelia burgdorferi infection.
    • Targeting PAF may represent a therapeutic strategy to mitigate inflammatory pathology in Lyme disease.
    • Further research is warranted to fully elucidate the mechanisms of PAF involvement.